Ripple Effect: Repackaged Losartan Recalled Due to Impurity – Medscape

Legacy Pharmaceutical Packaging LLC, based in Earth City, Missouri, has announced a nationwide recall to the consumer level of 40 repackaged lots of losartan tablets. This latest recall in the ongoing saga of contaminated sartan products stems from Camber Pharmaceuticals’ previously announced nationwide recall of losartan tablets found to contain trace amounts of the impurity N-nitroso-N-methyl-4-aminobutyric acid (NMBA) in the active pharmaceutical ingredient (API) made by Hetero Labs Ltd. NMBA is a known animal and potential human carcinogen. To date, Legacy has not received any reports of adverse events related to this recall. The recalled product are as follows: Recalled ...

Gepostet in der Kategorie Lebensweise (Anzahl der ansichten:) 3

Ähnlich Nachrichten